India  

Central Drugs Standard Control Organisation

Indian Apex Drug Regulatory Body

Central Drugs Standard Control Organisation    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Central Drugs Standard Control Organisation: Indian Apex Drug Regulatory Body
The Central Drugs Standard Control Organisation (CDSCO) is India's national regulatory body for cosmetics, pharmaceuticals and medical devices. It serves a similar function to the Food and Drug Administration (FDA) of the United States or the European Medicines Agency of the European Union. The Indian government has announced its plan to bring all medical devices, including implants and contraceptives under a review of the Central Drugs and Standard Control Organisation (CDSCO).

0
shares
ShareTweetSavePostSend
 

You Might Like


84 drug batches fail quality test, commonly used antacids, diabetes meds among them

The CDSCO's latest inspections revealed that 84 batches of commonly used drugs, including steroids and cholesterol reducers, did not meet quality standards. The apex body regularly identifies and..
IndiaTimes - Published

Bharat Biotech arm Biovet gets CDSCO nod for lumpy skin disease vax for cattle

Biovet, part of Bharat Biotech, has received approval from the CDSCO for its innovative lumpy skin disease vaccine, BIOLUMPIVAXIN, for dairy cattle and buffaloes. The vaccine, developed using a strain..
IndiaTimes - Published

No import allowed of refurbished medical devices: Regulator

The Central Drugs Standard Control Organisation has prohibited the import of second-hand or refurbished medical devices due to a lack of regulatory provisions, posing risks to patient safety. This move..
IndiaTimes - Published

Bring health supplements under drug control watch, suggests panel

An inter-ministerial committee has recommended that health supplements claiming to cure or mitigate diseases be classified as drugs. This shift aims to increase regulatory oversight by bringing these..
IndiaTimes - Published

Centre's lens on unapproved antibiotic combos, asks states to monitor availability

Centre requests states for licensed antibiotics. Study finds banned drugs still sold, with sales rising. Pharma firms promote new components to bypass rules, impacting resistance. CDSCO banned 26..
IndiaTimes - Published

Astra Zeneca gets nod for anticoagulant drug

AstraZeneca Pharma India announced that it has received approval from the Central Drugs Standard Control Organisation for the import and marketing of Andexanet Alfa. The therapy addresses..
IndiaTimes - Published

AstraZeneca gets CDSCO nod for drug to treat biliary tract cancer


IndiaTimes - Published